Linda Coleman

The animal health leader faces scrutiny in its Q2 earnings call after a rocky first quarter. All eyes are on its strategy to balance market pressures with future-focused bets.

Dash.fi just launched an AI platform to audit the complex costs of ads, shipping, and AI itself. It signals a major shift from tracking spend to actively recovering it.

Health Union's new AI suite aims to connect patients and doctors. But can algorithms truly capture the human element of care without compromising privacy?

Forget chasing political drama. A quiet revolution is reshaping forex, where government bond yields, not news, dictate currency trends. Here's why.

After a Q1 revenue miss, all eyes are on ICF's upcoming Q2 results. Can its booming commercial energy sector offset federal headwinds and validate its ambitious 2026 guidance?

A new collaboration brings a Swedish-engineered vein therapy to the U.S., offering hope to millions with CVI by replacing diseased tissue with a living graft.

Ashwin Rangan’s move to ReadyAI isn't just a new job. It’s a sign that for corporations, the chaotic era of AI experimentation is over and the age of governance has begun.

Toll Brothers' new Bulverde community highlights a Texas-sized boom in luxury living. But as one-acre lots sell, what is the cost to the community?

Telehealth firm Zealthy touts easy access to Zepbound, but a major federal lawsuit alleges a pattern of fraud, dangerous prescribing, and consumer deceit.

Wealthfront's new Custodial Account automates tax-saving for a child's future. But does its flexibility outweigh the significant risks to college financial aid?

Rachael Green's award is more than a trophy; it's a case study in how technical expertise and strategic vision are reshaping a legacy industry from the inside out.

A niche market for digital surveillance is set to triple, fueled by AI and 5G. But as firms like Vehere rise, so do profound questions about privacy.

James E. Pepper’s 1776 whiskey gets a label refresh, a strategic move blending deep history with modern marketing for the nation's Semiquincentennial.

Japan's digital audio market is soaring, but literal translation falls flat. A new localization model shows why cultural fluency is the key to being heard.

Longshot's $20M funding fuels its radical "space gun" to slash launch costs. Can this audacious kinetic tech disrupt the rocket-dominated aerospace industry?

Peachtree Group's new partnership with Goldman Sachs isn't just another deal. It's a strategic move that reveals the future of wealth management.

An influential OB-GYN is challenging the medical establishment to view menopause not as a niche issue, but as a core aging science, backing her call with a new foundation.

For decades, newborns with a common foot condition faced painful casting. Now, a simple, FDA-approved brace is disrupting pediatric care and bringing relief.

A Canadian firm's compact satellite is set to map the Moon's treacherous South Pole for the ESA, proving that the future of deep space exploration is smaller, smarter, and more collaborative.

Omnicom's new Acxiom Fan Graph promises to unify fragmented sports data. But can it deliver real ROI without crossing critical privacy lines?